Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 141-160
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Karthik Narayanaswamy Partner & Head of India at Novo Holdings | Mumbai, India | Family OfficePrivate equity | FinTechHardware | View profile | |
 Karen Spilizewski Managing Director at RiverVest Venture Partners | Cleveland, United States | Venture capital | HardwareHealthcare | View profile | |
 Mara Macdonald Investment Manager at Brandon Capital | Melbourne, Australia | Venture capital | Healthcare | View profile | |
 Jennifer Williams Partner and CFO at Genesys Capital | Toronto, Canada | Corporate VCVenture capital | AIHealthcare | View profile | |
 Kevin Kinsella Investor at Avalon Partners | San Diego, United States | Venture capital | AIConsumer | View profile | |
 Clay Maxwell Angel Investor at Duke Capital Partners | San Francisco, United States | AcceleratorSyndicate / Angel group | AIHardware | View profile | |
 Daniel Bahcheli Director at RA Capital Management | Boston, United States | Private equityVenture capital | FinTechHealthcare | View profile | |
 Maja Markovic Partner at Gimv | Munich, Germany | Private equity | ClimateFood | View profile | |
 Valentina Agostoni Principal at TVM Capital Life Science | Montreal, Canada | Venture capital | ConsumerHardware | View profile | |
 Zhaopei Liu Bioventure Associate at Hillhouse Investment | Beijing, China | Private equityVenture capital | AIClimate | View profile | |
 Tom Masterson Investor at Allele Capital Partners | Fort Lauderdale, United States | Private equityVenture debt | Healthcare | View profile | |
 Brian Chee Managing Partner at Polaris Partners | San Francisco, United States | Venture capital | AIHealthcare | View profile | |
 Stefan Fischer Managing Partner (Finance) bei TVM Capital Life Science at TVM Capital Life Science | Munich, Germany | Venture capital | ConsumerHardware | View profile | |
 Matthew Hammond Partner at RA Capital Management | Boston, United States | Private equityVenture capital | FinTechHealthcare | View profile | |
 Jack Slaughter Principal at Mountain Group Partners | Nashville, United States | Private equityVenture capital | ClimateConsumer | View profile | |
 Aaron Jacobson Director at Juvo Ventures | San Francisco, United States | Venture capital | AICommerce | View profile | |
 Kevin Bitterman Partner at Atlas Venture | Cambridge, United States | Venture capital | CommerceConsumer | View profile | |
 Minglin Ma Executive Director at Vertex Pharmaceuticals | Ithaca, United States | Corporate VCFamily Office | AIClimate | View profile | |
 Heather Preston General Partner at Oxonian Ventures | San Francisco, United States | Private equityVenture capital | AIConsumer | View profile | |
 George Petrocheilos Co-Founder & Managing Partner at Catalio Capital Management | New York, United States | Venture capitalVenture debt | AIHealthcare | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal